Daratumumab: COVID-19 Impact – Robert Rifkin – ASH 2022

Daratumumab: COVID-19 Impact – Robert Rifkin – ASH 2022 By Robert Rifkin, MD What is the Connect® MM Registry and how did COVID-19 impact multiple myeloma Patients? So this is a very interesting study in that it utilizes the Connect Multiple Myeloma Registry (Connect® MM Registry). The registry was established in 2009, and it’s one … Continue reading Daratumumab: COVID-19 Impact – Robert Rifkin – ASH 2022